Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure　― A Nationwide Survey in Japan ―-Reference-Cited by-同舟云学术

Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure　― A Nationwide Survey in Japan ―

Published:2018 Issue:4 Volume:82 Page:1155-1160
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Kuwabara Masanari¹²³,Niwa Koichiro²,Toyoda Tomohiko⁴,Shirai Takeaki⁵,Tateno Shigeru⁴,Ohuchi Hideo⁶,Tanaka Yasuhiko⁷,Ichida Fukiko⁸,Fujisawa Tomoo⁹,Akagi Teiji¹⁰,Mori Yoshiki¹¹,

Affiliation:

1. Department of Cardiology, Toranomon Hospital

2. Department of Cardiology, Cardiovascular Center, St. Luke’s International Hospital

3. Division of Renal Diseases and Hypertension, School of Medicine, University of Colorado Denver

4. Chiba Cardiovascular Center

5. Kakogawa City Hospital Organization

6. National Cerebral and Cardiovascular Center

7. Shizuoka Children’s Hospital

8. Department of Pediatrics, Faculty of Medicine, University of Toyama

9. Saiseikai Yokohama City Tobu Hospital

10. Cardiac Intensive Care Unit, Okayama University Graduate School of Medicine

11. Seirei Hamamatsu Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/82/4/82_CJ-17-1053/_pdf

Reference22 articles.

1. 1. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52: e143–e263.

2. 2. Kiesewetter CH, Sheron N, Vettukattill JJ, Hacking N, Stedman B, Millward-Sadler H, et al. Hepatic changes in the failing Fontan circulation. Heart 2007; 93: 579–584.

3. 3. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 2005; 129: 1348–1352.

4. 4. Asrani SK, Warnes CA, Kamath PS. Hepatocellular carcinoma after the Fontan procedure. N Engl J Med 2013; 368: 1756–1757.

5. 5. Martinez-Quintana E, Monescillo A, Rodriguez-Gonzalez F. Hepatocellular carcinoma in a non-failing Fontan circulation. Rev Esp Enferm Dig 2017; 109: 375.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Robot-assisted laparoscopic hepatectomy for hepatocellular carcinoma with Fontan-associated liver disease: a world-first case report;Surgical Case Reports;2024-09-09

2. Cancer mortality in children surviving congenital heart interventions: A study from the Pediatric Cardiac Care Consortium;Pediatric Blood & Cancer;2024-08-13

3. Risk of Cancer in Patients with Congenital Heart Disease: A Systematic Review and Meta-Analysis;Cardiology;2024-07-25

4. What we know and need to know about Fontan‐associated liver disease;Hepatology Research;2024-07-16

5. Epidemiology of Fontan‐associated liver disease in Japan: Results from a nationwide survey in 2021;Hepatology Research;2024-03-25